Individuals with severe sickle cell disease express high risk tolerance for gene therapies
Individuals living with severe sickle cell disease (SCD) are highly interested in new, potentially curative gene therapy treatments and are willing to accept associated risks for a chance at a cure, according to a study published today in Blood Advances. SCD is an inherited red blood cell disorder affecting approximately 100,000 people in the United …